Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Multiple sclerosis: Daclizumab HYP shows efficacy in patients with relapsing-remitting MS.
Saquinavir-NO inhibits S6 kinase activity, impairs secretion of the encephalytogenic cytokines interleukin-17 and interferon-gamma and ameliorates experimental autoimmune encephalomyelitis.
Relationship between NF-κB1 -94 ins/del ATTG polymorphism and susceptibility of multiple sclerosis in Iranian MS patients.
Helicobacter pylori infection reduces disease severity in an experimental model of multiple sclerosis.
Human endogenous retrovirus-K contributes to motor neuron disease.
Adjusted Indirect Comparison of Oral Multiple Sclerosis Agents.
Serum NSE and multiple sclerosis.
Comment on "Fingolimod effects on left ventricular function in multiple sclerosis" Mult Scler 2015.
Astrocytes Surviving Severe Stress Can Still Protect Neighboring Neurons from Proteotoxic Injury.
Deletion of caspase-8 in mouse myeloid cells blocks microglia pro-inflammatory activation and confers protection in MPTP neurodegeneration model.
Diversity Matters: A Revised Guide to Myelination.
Factors affecting dignity of patients with multiple sclerosis.
Recommendations for observational studies of comorbidity in multiple sclerosis.
Recurrent optic neuritis and neuromyelitis optica-IgG following first and second human papillomavirus vaccinations.
Cervical spinal cord volume loss is related to clinical disability progression in multiple sclerosis.
Teriflunomide.
Imaging multiple sclerosis outside the brain.
Inhibitors of myelination: ECM changes, CSPGs and PTPs.
Immunoenrichment microwave & magnetic (IM(2) ) proteomics for quantifying CD47 in the EAE model of multiple sclerosis.
Longitudinal 7-year follow-up of chronic pain in persons with multiple sclerosis in the community.
Hyperhomocysteinemia and neurologic disorders: a review.
Predictors of recurrence following an initial episode of transverse myelitis.
Current role of chemotherapy and bone marrow transplantation in multiple sclerosis.
The association between multiple sclerosis and fracture risk.
Alemtuzumab in the treatment of multiple sclerosis: key clinical trial results and considerations for use.

Pages